Industrial Microbiology Market is expected to gain market growth in the forecast period of 2022-2027
Industrial Microbiology Market is expected to gain market growth in the forecast period of 2022-2027
Share this Post to earn Money ( Upto ₹100 per 1000 Views )
According to MarkNtel Advisors study the Global Industrial Microbiology Market size is projected to grow at a CAGR of around 6.8% during the forecast period, i.e., 2022-27.
“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”
Access Free Sample Report - https://www.marknteladvisors.com/query/request-sample/global-industrial-microbiology-market
Key Findings of the Study: Industrial Microbiology market
Key Driver: Increasing Demand of Microbial Ingredients by the Pharmaceutical Industry and Focus on Drugs Development
Pharmaceutical companies depend heavily on microbiology owing to the growing innovation in novel drugs to treat various diseases. Increased R&D in clinical laboratories and the advent of rapid microbiological testing methods for vaccines & devices are the key drivers for the Global Industrial Microbiology Market through 2026.
Vaccines are required in large quantities due to the accelerating population & increasing number of diseases, which, in turn, has significantly boosted drug manufacturing worldwide. The US, Canada, India, & China are the leading pharmaceutical markets globally, with an immense demand for pharmaceutical products. China is one of the world’s leading producers & exporters of pharmaceutical products, owing to the increased R&D spending, technological advancements, & the growing prevalence of chronic diseases.
Furthermore, various pharmaceuticals companies have expanded their R&D and production to meet the burgeoning demand for drugs & vaccines, which shall also fuel the growth of the Global Industrial Microbial Market during 2022-27. For instance:
- In 2021, Sterling Pharma Solutions invested about USD 13.5 million in the manufacturing & development processes at its site in Dudley, UK. It includes building new development laboratories to meet the growing demand for Active Pharmaceutical Ingredient (API) manufacturing that contains microbiological ingredients.
For more detailed information about the Industrial Microbiology market report, click here – https://www.marknteladvisors.com/research-library/global-industrial-microbiology-market
Scope of the Report and Industrial Microbiology Market Segmentation:
By Products
- Equipment & Systems
- Filtration Systems
- Microbial Detection
- Incubators & Culture Systems
- Air Monitoring Systems
- Sterilization Systems
- Others
- Consumables
- Media
- Rapid Detection Assays
- Reagents & Supplements
- Accessories
By Applications
- Pharmaceuticals
- Clinical Laboratories
- Food & Beverages
- Cosmetics
- Construction
- Agriculture & Environment
- Other
By End Users
- Biotechnology and Pharmaceutical Companies
- Commercial Quality Assurance
- Research Institution
- Industrial
- Regulatory Bodies
The use of industrial microbiology has significantly increased in historical years due to the rapidly expanding pharmaceutical sector worldwide.
Industrial Microbiology Market Development:
- In 2020, Thermo Fisher Scientific Company acquired Phitonex Inc., a developer of a spectral dye platform for high-resolution biology applications for advancing R&D in cell therapy.
- In 2019, Biomerieux, the world leader in food microbiology testing, acquired Invisible Sentinel Inc., a leading manufacturer of molecular diagnostic tools that rapidly & effectively detect pathogens & harmful elements in food & beverages.
Geographical Analysis:
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia Pacific
Of all regions, North America is anticipated to dominate the market with the largest share during the forecast period, mainly due to the rapidly accelerating manufacturing of pharmaceuticals, healthcare systems, & laboratories across the region.
Note: If you require specific information not covered in the current report, we can provide it through customized option
Why choose Us?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India